The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.
The principal mechanisms that regulate the contractile state of VSMCs are changes in cytosolic Ca2+ concentration ([Ca2+]c). In response to vasoconstrictor stimuli, Ca2+ is mobilized from intracellular stores and/or the extracellular space to increase [Ca2+]c in VSMCs. The increase in [Ca2+]c, in turn, activates the Ca2+-CaM-MLCK pathway and stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, hence, the development of contractile force. The sensitivity of contractile myofilaments or MLC20 phosphorylation to Ca2+ can be secondarily modulated by other signaling pathways. During receptor stimulation, the contractile force is greatly enhanced by the inhibition of myosin phosphatase. Rho/Rho kinase, PKC, and arachidonic acid have been proposed to play a pivotal role in this enhancement.
The signaling events that mediate relaxation include the removal of a contractile agonist (passive relaxation) and activation of cyclic nucleotide-dependent signaling pathways in the continued presence of a contractile agonist (active relaxation). Active relaxation occurs through the inhibition of both Ca2+ mobilization and myofilament Ca2+ sensitivity in VSMCs.

Organismal Systems; Circulatory system
BRITE hierarchy

Loxodonta africana (African savanna elephant) [GN:lav]

PMID:17458653

Akata T

Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.

J Anesth 21:232-42 (2007)
DOI:10.1007/s00540-006-0488-4

PMID:12689814

Ogut O, Brozovich FV

Regulation of force in vascular smooth muscle.

J Mol Cell Cardiol 35:347-55 (2003)
DOI:10.1016/S0022-2828(03)00045-2

PMID:16339747

Hilgers RH, Webb RC

Molecular aspects of arterial smooth muscle contraction: focus on Rho.

Exp Biol Med (Maywood) 230:829-35 (2005)
DOI:10.1177/153537020523001107

PMID:12693609

Schlossmann J, Feil R, Hofmann F

Signaling through NO and cGMP-dependent protein kinases.

Ann Med 35:21-7 (2003)
DOI:10.1080/07853890310004093

PMID:16870827

Mehta PK, Griendling KK

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Am J Physiol Cell Physiol 292:C82-97 (2007)
DOI:10.1152/ajpcell.00287.2006

PMID:19120701

Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG

Smooth muscle signalling pathways in health and disease.

J Cell Mol Med 12:2165-80 (2008)
DOI:10.1111/j.1582-4934.2008.00552.x

PMID:11165670

Fukata Y, Amano M, Kaibuchi K

Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.

Trends Pharmacol Sci 22:32-9 (2001)
DOI:10.1016/S0165-6147(00)01596-0

PMID:17158339

Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T

Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.

Circ Res 100:121-9 (2007)
DOI:10.1161/01.RES.0000253902.90489.df

PMID:17200683

Hynynen MM, Khalil RA

The vascular endothelin system in hypertension--recent patents and discoveries.

Recent Pat Cardiovasc Drug Discov 1:95-108 (2006)
DOI:10.2174/157489006775244263

PMID:15269340

Brain SD, Grant AD

Vascular actions of calcitonin gene-related peptide and adrenomedullin.

Physiol Rev 84:903-34 (2004)
DOI:10.1152/physrev.00037.2003

PMID:11773611

Roman RJ

P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Physiol Rev 82:131-85 (2002)
DOI:10.1152/physrev.00021.2001

PMID:18040024

Surks HK

cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms.

Circ Res 101:1078-80 (2007)
DOI:10.1161/CIRCRESAHA.107.165779

PMID:15026027

Vanhoutte PM

Endothelium-dependent hyperpolarizations: the history.

Pharmacol Res 49:503-8 (2004)
DOI:10.1016/j.phrs.2003.11.015

PMID:10221985

Davis MJ, Hill MA

Signaling mechanisms underlying the vascular myogenic response.

Physiol Rev 79:387-423 (1999)
DOI:10.1152/physrev.1999.79.2.387

PMID:11679404

Fleming I.

Cytochrome p450 and vascular homeostasis.

Circ Res 89:753-62 (2001)
DOI:10.1161/hh2101.099268

PMID:10911373

Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP

Molecular mechanism of cGMP-mediated smooth muscle relaxation.

J Cell Physiol 184:409-20 (2000)
DOI:10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K

PMID:18552454

Ko EA, Han J, Jung ID, Park WS

Physiological roles of K+ channels in vascular smooth muscle cells.

J Smooth Muscle Res 44:65-81 (2008)
DOI:10.1540/jsmr.44.65

PMID:18703404

Woodard GE, Rosado JA

Natriuretic peptides in vascular physiology and pathology.

Int Rev Cell Mol Biol 268:59-93 (2008)
DOI:10.1016/S1937-6448(08)00803-4

PMID:11709400

Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG

Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.

Am J Physiol Heart Circ Physiol 281:H2337-65 (2001)
DOI:10.1152/ajpheart.2001.281.6.H2337

PMID:15725705

Hirano K, Hirano M, Kanaide H

Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle.

J Smooth Muscle Res 40:219-36 (2004)
DOI:10.1540/jsmr.40.219

PMID:9458738

Freeman EJ, Ruehr ML, Dorman RV

ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells.

Am J Physiol 274:C282-8 (1998)
DOI:10.1152/ajpcell.1998.274.1.C282

PMID:12060106

Murphy TV, Spurrell BE, Hill MA

Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways.

Clin Exp Pharmacol Physiol 29:612-9 (2002)
DOI:10.1046/j.1440-1681.2002.03698.x